Postoperative hydrocephalus in patients with infratentorial brain metastases may be influenced by preoperative treatment: a single-center cohort study - Top-Institutions - MDSpire

Postoperative hydrocephalus in patients with infratentorial brain metastases may be influenced by preoperative treatment: a single-center cohort study

  • By

  • Luisa Mona Kraus

  • Maria Goldberg

  • Eugen Ursu

  • Kayra Demirbag

  • Simon Paul Backhaus

  • Ghaith Altawalbeh

  • Denise Bernhardt

  • Chiara Negwer

  • Stephanie Combs

  • Bernhard Meyer

  • Arthur Wagner

  • June 23, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Neuroradiology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Radiation Oncology

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Neuropathology

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Neuroradiology

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Neuroradiology

Original Source(s)

Postoperative hydrocephalus in patients with infratentorial brain metastases may be influenced by preoperative treatment: a single-center cohort study

  • by Luisa Mona Kraus, Maria Goldberg, Eugen Ursu, Kayra Demirbag, Simon Paul Backhaus, Ghaith Altawalbeh, Denise Bernhardt, Chiara Negwer, Stephanie Combs, Bernhard Meyer, Arthur Wagner

  • June 23, 2025

Related Content

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

Papillary thyroid carcinoma with brain and lung metastases: a case report

Overcoming absolute dysphagia in a thirty-year-old patient with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: a case report